not hungry at all on semaglutide Struggling with energy, cravings, or early signs of insulin resistance? microdosing is a lower-dose, clinician-prescribed GLP-1 medication designed to support metabolic health, appetite regulation, and insulin sensitivity**—without a Why am I still hungry

From December 2024 to January 2, 2025, 31 people joined the MDL

Topamax can also cause gastrointestinal disturbances, including nausea and altered taste (dysgeusia)

Common gaps in initial submissions: Detailed diet and exercise log covering at least 12 weeks Documentation of supervised weight loss attempts (dietitian visits, weight management program enrollment) Lab work showing obesity-related metabolic abnormalities (elevated HbA1c, lipid panel, liver enzymes) Sleep study confirming obstructive sleep apnea Imaging or clinical notes documenting osteoarthritis or other mechanical complications of obesity Step 3: Physician letter of medical necessity

Committee ADAP, Committee ADAP

Practical Portion Strategies and Timing on GLP-1 Therapy Most patients on GLP-1 medications tolerate watermelon best in small portionsroughly to 1 cup (75150 grams)consumed after a protein-containing meal rather than alone

Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Insulin Glargine as Add-on to Metformin (With or Without Sulfonylureas) in Insulin-Naive Patients With Type 2 Diabetes (SUSTAIN 4): A Randomised, Open-Label, Parallel-Group, Multicentre, Mul